Literature DB >> 19263009

Doping and the Olympic games: the good, the bad, and the ugly.

Mitja Lainscak1, Josko Osredkar.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19263009     DOI： 10.1007/s00508-008-1121-3

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN： 0043-5325            Impact factor:   1.704


× No keyword cloud information.
  16 in total

1.  Past, present, and future of drug abuse at the Olympics.

Authors:  K Birchard
Journal:  Lancet       Date:  2000-09-16       Impact factor: 79.321

2.  Gene therapy may be up to speed for cheats at 2008 Olympics.

Authors:  D Adam
Journal:  Nature       Date:  2001-12-06       Impact factor: 49.962

3.  Medication use in athletes selected for doping control at the Sydney Olympics (2000).

Authors:  Brian Corrigan; Rymantas Kazlauskas
Journal:  Clin J Sport Med       Date:  2003-01       Impact factor: 3.638

4.  Doping control from a global and national perspective.

Authors:  Albert D Fraser
Journal:  Ther Drug Monit       Date:  2004-04       Impact factor: 3.681

5.  Rogue athletes and recombinant DNA technology: challenges for doping control.

Authors:  Hassan M E Azzazy; Mai M H Mansour
Journal:  Analyst       Date:  2007-07-31       Impact factor: 4.616

6.  History of mass spectrometry at the Olympic Games.

Authors:  Peter Hemmersbach
Journal:  J Mass Spectrom       Date:  2008-07       Impact factor: 1.982

7.  Finishing the euchromatic sequence of the human genome.

Authors: 
Journal:  Nature       Date:  2004-10-21       Impact factor: 49.962

Review 8.  beta2-Agonists at the Olympic Games.

Authors:  Kenneth D Fitch
Journal:  Clin Rev Allergy Immunol       Date:  2006 Oct-Dec       Impact factor: 8.667

9.  Side effects of anabolic androgenic steroids abuse.

Authors:  A Bonetti; F Tirelli; A Catapano; D Dazzi; A Dei Cas; F Solito; G Ceda; C Reverberi; C Monica; S Pipitone; G Elia; M Spattini; G Magnati
Journal:  Int J Sports Med       Date:  2007-11-14       Impact factor: 3.118

10.  Current anti-doping policy: a critical appraisal.

Authors:  Bengt Kayser; Alexandre Mauron; Andy Miah
Journal:  BMC Med Ethics       Date:  2007-03-29       Impact factor: 2.652
View more
  3 in total

1.  Doping awareness, views, and experience: a comparison between general practitioners and pharmacists.

Authors:  Irena Auersperger; Mojca Doupona Topič; Petra Maver; Vika Kuferšin Pušnik; Joško Osredkar; Mitja Lainščak
Journal:  Wien Klin Wochenschr       Date:  2011-10-28       Impact factor: 1.704

Review 2.  [Interdisciplinary strategies versus doping].

Authors:  Karin Vitzthum; Stefanie Mache; David Quarcoo; David A Groneberg; Norman Schöffel
Journal:  Wien Klin Wochenschr       Date:  2010-06       Impact factor: 1.704

3.  Growth hormone, insulin-like growth factor 1, and insulin signaling-a pharmacological target in body wasting and cachexia.

Authors:  Katja Trobec; Stephan von Haehling; Stefan D Anker; Mitja Lainscak
Journal:  J Cachexia Sarcopenia Muscle       Date:  2011-10-20       Impact factor: 12.910
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.